| Date Filed | Type | Description |
| 08/25/2023 |
4
| Salkind Gene Z (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Exercised 117,647 shares
@ $0.265, valued at
$31.2k
Granted 117,647 options to buy
@ $0.7, valued at
$82.4k
|
|
| 08/21/2023 |
4
| Salkind Gene Z (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Granted 186,364 options to buy
@ $0.11, valued at
$20.5k
|
|
| 08/21/2023 |
4
| BAGG GERALD (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Granted 186,364 options to buy
@ $0.11, valued at
$20.5k
|
|
| 08/21/2023 |
4
| Costantino Robert J (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Granted 186,364 options to buy
@ $0.11, valued at
$20.5k
|
|
| 08/21/2023 |
4
| Davidson Robert Steven (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Granted 186,364 options to buy
@ $0.11, valued at
$20.5k
|
|
| 08/21/2023 |
4
| Salkind Gene Z (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Granted 341,667 options to buy
@ $0.24, valued at
$82k
|
|
| 08/21/2023 |
4
| BAGG GERALD (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Granted 13,491 options to buy
@ $0.12, valued at
$1.6k
|
|
| 08/21/2023 |
4
| Costantino Robert J (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Granted 29,486 options to buy
@ $0.12, valued at
$3.5k
|
|
| 08/21/2023 |
4
| Davidson Robert Steven (Director) has filed a Form 4 on Avenir Wellness Solutions, Inc.|
Txns:
| Granted 13,491 options to buy
@ $0.12, valued at
$1.6k
|
|
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/11/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 07/28/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 07/28/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 05/15/2023 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 04/20/2023 |
8-K
| Quarterly results |
| 04/19/2023 |
8-K
| Quarterly results |
| 03/31/2023 |
NT 10-K
| Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405: |
| 03/08/2023 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 01/17/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and ... |
| 11/21/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/14/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 09/15/2022 |
4
| BAGG GERALD (Director) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Granted 220,795 shares
@ $0 |
|
| 09/13/2022 |
4
| Costantino Robert J (Director) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Granted 226,764 shares
@ $0 |
|
| 09/13/2022 |
4
| Davidson Robert Steven (Director) has filed a Form 4 on Cure Pharmaceutical Holding Corp.|
Txns:
| Granted 220,795 shares
@ $0 |
|
| 09/02/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/23/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/22/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/22/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/19/2022 |
8-K
| Quarterly results |
| 08/16/2022 |
NT 10-Q
| Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB: |
| 07/28/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
|